ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
India's Drugs Consultative Committee will consider a proposal to bring all sterile drug products under central licensing oversight. The move aims to create a uniform regulatory system and tighten rules for medicines prone to microbial contamination.
Tap to vote and see what everyone thinks.
Summary by ByteBrief